文献速递肿瘤 PET/CT

PET影像组学用于非小细胞肺癌组织学亚型分类:系统综述与Meta分析

PET radiomics for histologic subtype classification of non-small cell lung cancer: a systematic review and meta-analysis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-01-11

该系统综述与Meta分析纳入12项研究,评估PET影像组学鉴别非小细胞肺癌中腺癌与鳞状细胞癌的效能,汇总AUC为0.92(95%CI:0.89-0.94),但研究间异质性高(灵敏度I²=92.20%,特异度I²=89.29%),方法学质量中位RQS为11/36。

要点

  • PET影像组学鉴别腺癌与鳞癌的汇总AUC为0.92(95%CI:0.89-0.94)。
  • 研究间异质性显著,灵敏度I²=92.20%,特异度I²=89.29%。
  • 方法学质量有限,中位RQS为11/36。

核心结论

  • PET影像组学在区分腺癌与鳞状细胞癌方面具有潜在应用价值,但观察到的较高异质性表明纳入研究间存在显著的方法学差异。

研究设计与样本

  • 系统检索PubMed、Embase、Scopus和Web of Science数据库,检索时限为建库至2024年11月,纳入英文人类研究,最终纳入12项研究。
  • 使用QUADAS-2工具和影像组学质量评分(RQS)评估纳入研究的方法学质量。
  • 采用随机效应模型合并AUC以估计预测效能,通过I²值评估统计异质性,并进行亚组分析探索异质性来源。

主要发现

  • 12项研究的汇总AUC为0.92(95%CI:0.89-0.94)。
  • 灵敏度异质性I²为92.20%(95%CI:89.01-95.39),特异度异质性I²为89.29%(95%CI:84.48-94.10)。
  • 纳入研究的方法学质量中位RQS为11/36,研究设计和方法学质量均存在局限性。

关键数值与推荐

  • 汇总AUC为0.92(95%CI:0.89-0.94),用于评估PET影像组学区分腺癌与鳞癌的预测效能。
  • 灵敏度I²=92.20%(95%CI:89.01-95.39),特异度I²=89.29%(95%CI:84.48-94.10)。
  • 中位RQS为11/36。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 纳入研究在study design和方法学质量方面存在局限性,中位RQS为11/36。
  • 研究间观察到显著异质性,灵敏度I²为92.20%(95%CI:89.01-95.39),特异度I²为89.29%(95%CI:84.48-94.10)。
  • 未来研究应关注标准化、透明性和多中心合作,以提高PET影像组学用于NSCLC组织学亚型分类的可靠性和临床适用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC). METHODS: PubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies on distinguishing adenocarcinoma (ADC) from squamous cell carcinoma (SCC) using PET radiomics published from inception until November 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Radiomics Quality Score (RQS) were utilized to assess the methodological quality of the included studies. The area under the receiver operating characteristic curves (AUC) was pooled to estimate predictive performance. An overall effect size was estimated using a random-effects model. Statistical heterogeneity was evaluated by the I2 value. Subgroup analyses were conducted to explore sources of heterogeneity. RESULTS: Twelve studies were included in the analysis, yielding a pooled AUC of 0.92 (95% confidence interval [CI]: 0.89-0.94). Despite this promising result, the studies showed limitations in both study design and methodological quality, as evidenced by a median RQS of 11/36. A significant degree of heterogeneity was observed among the studies, with an I2 of 92.20% (95% CI: 89.01-95.39) for sensitivity and 89.29% (95% CI: 84.48-94.10) for specificity. CONCLUSIONS: This meta-analysis highlights the potential utility of PET radiomics in distinguishing ADC from SCC. However, the observed high heterogeneity indicates substantial methodological variability across the included studies. Future research should focus on standardization, transparency, and multicenter collaborations to improve the reliability and clinical applicability of PET radiomics for histologic subtype classification in NSCLC.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Zhang J, Zhang X, Zhong Y, et al. PET radiomics for histologic subtype classification of non-small cell lung cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2025. PMID: 39794511. doi:10.1007/s00259-025-07069-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。